Evaluation of detection of extended-spectrum beta-lactamases among Escherichia coli and Klebsiella spp. isolates by VITEK 2 AST-N029 compared to the agar dilution and disk diffusion methods

Scandinavian Journal of Infectious Diseases

Volumn 40, Issue 5, 2008, Pages 355-362

  Nyberg, Sofia D ^a   Meurman, Olli ^b   Jalava, Jari ^a   Rantakokko Jalava, Kaisu ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CEFOTAXIME; CEFPIROME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CLAVULANATE POTASSIUM; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE;

ACCURACY; AGAR DILUTION; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DEVICE; DISK DIFFUSION; ENZYME ANALYSIS; ESCHERICHIA COLI; GENOTYPE; KLEBSIELLA; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; NONHUMAN; PHENOTYPE;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; ESCHERICHIA COLI; HUMANS; KLEBSIELLA; MICROBIAL SENSITIVITY TESTS; SENSITIVITY AND SPECIFICITY;

EID: 42449127102     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540701704706     Document Type: Article

References (28)

1. Bonnet, R. (2004) Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother, 48, pp. 1-14.
2. Jacoby, JA and Bush, K. Amino acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor resistant β-lactamases.
3. Jacoby, GA and Munoz-Price, LS. (2005) The new beta-lactamases. N Engl J Med, 352, pp. 380-391.
4. Livermore, DM and Williams, JD (1996) pp. 502-578. Williams & Wilkins, Baltimore
5. Livermore, DM and Brown, DFJ. (2001) Detection of β-lactamase-mediated resistance. J Antimicrob Chemother, 48, pp. 59-64.
6. Ramphal, R. and Ambrose, PG. (2006) Extended-spectrum beta-lactamases and clinical outcomes: Current data. Clin Infect Dis, 42, p. S164.
7. Clinical and Laboratory Standards Institute (2007)26, M7-A7, Wayne, Pa
8. Livermore, DM and Brown, DFJ. (2005) Detection of β-lactamase-mediated resistance.
9. Clinical and Laboratory Standards Institute (2007) Approved Standard, M2-A9, Wayne, PA
10. Jossart, MF and Courcol, RJ. (1999) Evaluation of an automated system for identification of Enterobacteriaceae and non-fermenting bacilli. Eur J Clin Microbiol Infect Dis, 18, pp. 902-907.
11. Livermore, DM, Struelens, M., Amorim, J., Baquero, F., Bille, J. and Canton, R. (2002) Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests. J Antimicrob Chemother, 49, pp. 289-300.
12. Sanders, CC, Peyret, M., Moland, ES, Shubert, C., Thomson, KS and Boeufgras, J-M (2000) Ability of the VITEK 2 Advanced Expert System to identify beta-lactam phenotypes in isolates of Enterobacteriaceae and Pseudomonas aeruginosa. J Clin Microbiol, 38, pp. 570-574.
13. Nyberg, SD, Österblad, M., Hakanen, AJ, Huovinen, P. and Jalava, J. (2007) the Finnish Study Group for Antimicrobial Resistance. Detection and molecular genetics of extended-spectrum beta-lactamases among cefuroxime-resistant Escherichia coli and Klebsiella spp. isolates from Finland, 2002-2004. Scand J Infect Dis, 39, pp. 417-424.
14. Sorlozano, A., Gutierrez, J., Piedrola, G. and Soto, MJ. (2005) Acceptable performance of VITEK 2 system to detect extended-spectrum beta-lactamases in clinical isolates of Escherichia coli: A comparative study of phenotypic commercial methods and NCCLS guidelines. Diagn Microbiol Infect Dis, 51, pp. 191-193.
15. Spanu, T., Sanguinetti, M., Tumbarello, M., D'Inzeo, T., Fiori, B. and Posteraro, B. (2006) Evaluation of the New VITEK 2 Extended-Spectrum Beta-Lactamase (ESBL) Test for rapid detection of ESBL production in Enterobacteriaceae isolates. J Clin Microbiol, 44, pp. 3257-3262.
16. Schwaber, MJ, Navon-Venezia, S., Chmelnitsky, I., Leavitt, A., Schwartz, D. and Carmeli, Y. (2006) Utility of the VITEK 2 Advanced Expert System for identification of extended-spectrum beta-lactamase production in Enterobacter spp. J Clin Microbiol, 44, pp. 241-243.
17. Dashti, AA, West, P., Paton, R. and Amyes, SGB. (2006) Characterization of extended-spectrum beta-lactamase (ESBL)-producing Kuwait and UK strains identified by the Vitek system, and subsequent comparison of the Vitek system with other commercial ESBL-testing systems using these strains. J Med Microbiol, 55, pp. 417-421.
18. Rantakokko-Jalava, K., Elo-Lehtonen, E. and Meurman, O. (2006) Comparison of workflow and accuracy of identification and antimicrobial susceptibility testing of clinical isolates of Enterobacteriaceae, Pseudomonas aeruginosa and enterococci by Vitek 2 and routine methods. APMIS, 114, pp. 43-49.
19. Ziegler, R., Johnscher, I., Martus, P., Lenhardt, D. and Just, HM. (1998) Controlled clinical laboratory comparison of two supplemented aerobic and anaerobic media used in automated blood culture systems to detect bloodstream infections. J Clin Microbiol, 36, pp. 657-661.
20. Schiappa, DA, Hayden, MK, Matushek, MG, Hashemi, FN, Sullivan, J. and Smith, KY (1996) Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: A case-control and molecular epidemiological investigation. J Infect Dis, 174, pp. 529-536.
21. Schwaber, MJ, Navon-Venezia, S., Kaye, KS, Ben-Ami, R., Schwartz, D. and Carmeli, Y. (2006) Clinical and economic impact of bacteraemia with extended-spectrum beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother, 50, pp. 1257-1262.
22. Andes, D. and Craig, WA. (2005) Treatment of infections with ESBL-producing organisms: Pharmacokinetic and pharmacodynamic considerations. Clin Microbiol Infect, 11, pp. 10-17.
23. Paterson, DL and Bonomo, RA. (2005) Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev, 18, pp. 657-686.
24. Potz, NA, Colman, M., Warner, M., Reynolds, R. and Livermore, DM. (2004) False positive extended-spectrum beta-lactamase tests for Klebsiella oxytoca strains hyperproducing K1 β-lactamase. J Antimicrob Chemother, 53, pp. 545-547.
25. Fournier, B. and Roy, PH. (1997) Variability of chromosomally encoded β-lactamases from Klebsiella oxytoca. Antimicrob Agents Chemother, 41, pp. 1641-1648.
26. Hanson, ND. (2003) AmpC β-lactamases: What do we need to know for the future?. J Antimicrob Chemother, 52, pp. 2-4.
27. Pfaller, MA and Segreti, J. (2006) Overview of the epidemiological profile and laboratory detection of extended-spectrum β-lactamases. Clin Infect Dis, 42, p. S153.
28. Nasim, K., Elsayed, S., Pitout, JD, Conly, J., Church, DL and Gregson, DB. (2004) New method for laboratory detection of AmpC β-lactamases in Escherichia coli and Klebsiella pneumoniae. J Clin Microbiol, 42, pp. 4799-4802.